Duplicate Document
This document appears to be a copy. The original version is:
Swiss and French CBD Market Overview and Recent Corporate PartnershipsCase Filekaggle-ho-024899House OversightSwiss and French CBD Market Overview and Recent Corporate Partnerships
Unknown1p2 persons
Swiss and French CBD Market Overview and Recent Corporate Partnerships
Swiss and French CBD Market Overview and Recent Corporate Partnerships The passage provides a general regulatory summary and mentions several corporate partnerships in the European CBD industry, but it lacks specific allegations, financial flows, or involvement of high‑profile political or intelligence figures. The information is largely public and offers limited actionable leads for investigative follow‑up. Key insights: Switzerland’s Federal Food Safety and Veterinary Office (FOPH) is tightening enforcement on CBD products for false claims.; From 2017‑2018, Swiss cannabis firms dropped from ~500 to ~100, with some focusing on export markets.; LGC Capital partnered with Swiss cultivator Viridi; Wayland acquired Haxon AG; Creso Pharma Limited signed an agreement with Hempmate Zurich AG.
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.